Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New sphingosine 1-phosphate receptor antagonists reported by Galapagos

Jan. 29, 2019

I-Mab Biopharma begins first-in-human study of TJ-003234

Jan. 28, 2019

Results from phase I/II study of rituximab biosimilar ABP-798 in rheumatoid arthritis

Jan. 25, 2019

Study more than doubles known osteoarthritis risk genes

Jan. 25, 2019

KZR-616, a dual immunoproteasome subunit inhibitor for autoimmune diseases

Jan. 24, 2019

Bio-Thera begins phase III study of tocilizumab biosimilar BAT-1806

Jan. 23, 2019

Anti-SIRT1 autoantibodies as a marker for ankylosing spondylitis diagnosis

Jan. 16, 2019

Pluristem reports successful case study in treatment of Buerger's disease patient

Jan. 11, 2019

Idorsia begins multiple-dose study of cenerimod for SLE

Jan. 7, 2019

Galapagos initiates phase IIa study of GLPG-1690 in systemic sclerosis

Jan. 7, 2019

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...